Drugs / Human chorionic gonadotropin (HCG)
Trials 1 · a red edge is where a trial was stopped
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 2 | NCT02147964 | Jun 2019 → Dec 2021 | hypogonadotropic hypogonadism | University of Washington | Withdrawn | No outcome recorded |
Evidence & citations 3 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Human chorionic gonadotropin (HCG) | “Human chorionic gonadotropin (HCG)” NCT02147964 ↗ |
| Known as | HCG | ClinicalTrials.gov intervention name — accepted as the source's own label NCT02147964 ↗ |
| Route | Subcutaneous | “HCG 60 IU injection Subcutaneously” NCT02147964 ↗ |